mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.0021 |
1 |